neoplasm
• tumors are most commonly seen in the spleen, mesenteric lymph nodes, liver, and intestines
• tumors are present in 20 of 25 mice at 18-26 months of age compared to 5 of 19 wild-type controls
|
• tumors in the lower gastrointestinal tract often lead to destruction of the mucosal surface
|
• some mice have histiocyte-associated lymphoma or B cell lymphoma co-occurring with histiocytic sarcoma
|
• tumor cell morphology is frequently consistent with malignant histiocytes, although in some mice tumors have a plasma cell appearance
|
hematopoietic system
• frequently enlarged due to proliferation of transformed cells
|
• cells from 8-12 week old mice display enhanced viability in response to LPS in culture
|
• splenocytes from 8-12 week old mice display enhanced viability in response to LPS in culture
|
immune system
• frequently enlarged due to proliferation of transformed cells
|
• splenocytes from 8-12 week old mice display enhanced viability in response to LPS in culture
|
• frequently enlarged due to proliferation of transformed cells
|
liver/biliary system
digestive/alimentary system
• tumors in the lower gastrointestinal tract often lead to destruction of the mucosal surface
|
growth/size/body
• frequently enlarged due to proliferation of transformed cells
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
malignant histiocytic disease | DOID:2570 | J:282928 |